X4 Pharmaceuticals, Inc.
XFOR
$4.10
$0.030.74%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 147.89% | -9.47% | -62.70% | 7.52% | -10.64% |
| Total Receivables | -66.49% | 49.67% | 118.38% | 67.24% | 204.27% |
| Inventory | 59.00% | 66.87% | 281.47% | -- | -- |
| Prepaid Expenses | -54.83% | 5.00% | -0.42% | -22.20% | -20.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 133.19% | -7.11% | -58.42% | 9.58% | -8.11% |
|
|
|||||
| Total Current Assets | 133.19% | -7.11% | -58.42% | 9.58% | -8.11% |
| Net Property, Plant & Equipment | -67.13% | -62.33% | -48.94% | -31.09% | -24.30% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -7.50% | -7.36% | -7.23% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -66.73% | -16.72% | 31.36% | 101.94% | 44.85% |
| Total Assets | 98.34% | -8.20% | -50.07% | 15.89% | -0.55% |
|
|
|||||
| Total Accounts Payable | -33.93% | -41.09% | -3.47% | 24.40% | -3.64% |
| Total Accrued Expenses | -19.13% | -15.52% | -33.83% | -6.40% | 79.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -20.54% | -1.80% | 16.72% | 15.00% | 13.83% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -21.66% | -19.66% | -20.78% | 9.95% | 43.81% |
|
|
|||||
| Total Current Liabilities | -21.66% | -19.66% | -20.78% | 9.95% | 43.81% |
| Long-Term Debt | 1.15% | 1.11% | 1.08% | 37.95% | 38.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -94.59% | -59.77% | -52.16% | -46.02% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -85.44% | -81.53% | -83.88% | -85.40% | -9.49% |
| Total Liabilities | -16.19% | -14.01% | -12.88% | -3.67% | 29.26% |
|
|
|||||
| Common Stock & APIC | 45.26% | 18.14% | 2.15% | 1.37% | 1.61% |
| Retained Earnings | -15.37% | -20.00% | -23.24% | 2.76% | -7.84% |
| Treasury Stock & Other | 10.66% | -3.51% | 13.21% | 17.42% | -2.52% |
| Total Common Equity | 741.08% | 3.35% | -95.80% | 2,114.67% | -56.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 741.08% | 3.35% | -95.80% | 2,114.67% | -56.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 741.08% | 3.35% | -95.80% | 2,114.67% | -56.65% |
|
|
|||||